Revenue
2022
2023
2024
2025
Curanex Pharmaceuticals Inc (CURX)
Price$5.05Cached quote
Net income
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $26,000 |
| Research & development | $3.0M | $0 | — | — |
| Operating expenses | $4.2M | $365,062 | $19,298 | $24,662 |
| Operating income | −$4.2M | −$365,062 | −$19,298 | −$20,233 |
| Operating margin | — | — | — | −77.82% |
| EBITDA | −$4.1M | −$361,506 | −$17,483 | $925 |
| EBITDA margin | — | — | — | 3.56% |
| Net income | −$4.2M | −$361,506 | −$19,198 | −$20,233 |
| Net profit margin | — | — | — | −77.82% |
| Basic EPSper basic share | -$0.17 | -$0.03 | -$0.01 | -$0.40 |
| Diluted EPSper diluted share | -$0.17 | -$0.03 | -$0.01 | -$0.40 |
Owners
Reported shareholders
0.34%of listed shares
CITADEL ADVISORS LLC95.26K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
CITADEL ADVISORS LLC | 0.34%95.26K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.18%52K shares |
Virtu Financial LLC | 0.18%51.24K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.13%38.29K shares |
JANE STREET GROUP, LLC | 0.11%31.22K shares |
TWO SIGMA INVESTMENTS, LP | 0.10%27.35K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05%14.66K shares |
Ground Swell Capital, LLC | 0.04%12.64K shares |
CITIGROUP INC | 0.03%8.96K shares |
UBS Group AG | <0.01%1.51K shares |
Tower Research Capital LLC (TRC) | <0.01%1K shares |
Jing Dian Ying | —— shares |
Liu Jun | —— shares |
Liu Chang | —— shares |
Percentages use 28.36M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data